ÀÏÁ¤Ç¥

  • - ÀϽÃ: 2025³â 4¿ù 12ÀÏ(Åä) 08:50-16:50
  • - Àå¼Ò: ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
  • - ÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ 6ÆòÁ¡

´ëÇÐȸÀå(ÄÁº¥¼ÇȦ)

08:50-09:00 Opening Remark ¡¡
Session¥°  Biomarker and Drug Discovery of Sarcopenia
ÁÂÀå: ÀåÇÐö(¼­¿ïÀÇ´ë), ·ùµ¿·Ä(GIST)
09:00-09:25 Exploring Sarcopenia Biomarkers and Therapeutic Targets Through Animal Models ±è¹üÁØ ±³¼ö (¿ï»êÀÇ´ë)
09:25-09:50 Mitochondrial Metabolic Reprogramming to Combat Sarcopenia °­Á¾¼ø ±³¼ö (¼º±Õ°ü´ë)
09:50-10:15 Serotonin: A Novel Therapeutic Target for Sarcopenia ¿Àâ¸í ±³¼ö (GIST)
Session ¥±  Keynote Session
ÁÂÀå: ±è´öÀ± (°æÈñÀÇ´ë)
10:15-10:50 Targeting the GDF15-GFRAL Axis in the Dorsal Vagal Complex with a Dual Therapeutic Strategy for Cancer-associated Cachexia ¼Û¹ÎÈ£ ±³¼ö (KAIST)
10:50-11:00 Coffee Break ¡¡
Session ¥²  Cachexia and Sarcopenia in Older Adults with Cancer
ÁÂÀå: ¹ÚÇü¹« (±×·¹À̽ºº´¿ø), °í¼¼ÀÏ (°æ»óÀÇ´ë)
11:00-11:25 Cancer Cachexia ³ë¿ëÈ£ ±³¼ö (Áß¾ÓÀÇ´ë)
11:25-11:50 Sarcopenia and Cancer ¹Ú¼ÛÀÌ ±³¼ö (Áß¾ÓÀÇ´ë)
11:50-12:15 Combatting Cancer-Related Muscle Wasting: New Insights and Therapies for Cachexia and Sarcopenia °í¼¼ÀÏ ±³¼ö (°æ»óÀÇ´ë)
12:15-12:30 Discussion ¡¡
Luncheon Symposium & Lunch
ÁÂÀå: ±èųâ (ÀÎÁ¦ÀÇ´ë)
12:30-13:30 1. ±Ù°¨¼ÒÁõ ȯÀÚ¿¡¼­ Å×½ºÅ佺Å×·ÐÀÇ »ç¿ë
2. ½º¸¶Æ® ÀμÖÀ» ÀÌ¿ëÇÑ ±Ù°¨¼ÒÁõ ȯÀÚ °ü¸®
À¯ÁØÀÏ ±³¼ö (ÀÎÇÏÀÇ´ë)
Session IV  Muscle Loss in Obesity Treatment: Challenges and Strategies
ÁÂÀå: ¿øÀå¿ø (°æÈñÀÇ´ë), È«¼ººó (ÀÎÇÏÀÇ´ë)
13:30-14:00 Understanding Muscle Loss during Weight Loss: Mechanisms and Risk Factors ¹Ú°è¿µ ±³¼ö (ÇѾçÀÇ´ë)
14:00-14:30 Body composition changes induced by GLP-1RA-based therapies: Impact of muscle loss on health outcomes ¹èÀçÇö ±³¼ö (¼­¿ïÀÇ´ë)
14:30-15:00 Preventing and Managing Muscle Loss in Obesity: Current Approaches and Future Directions ÀÌÁØ¿± ±³¼ö (Ä«Å縯ÀÇ´ë)
15:00-15:20 Coffee Break ¡¡
Session ¥´  Interventional Management of Sarcopenia
ÁÂÀå: ¹Ú¿ë¼ø (ÇѾç´ëÇб³), ¹ÚÇöÅ (µ¿¾Æ´ëÇб³)
15:20-15:45 Exercise and Rehabilitation Strategies for Sarcopenia Management ±èÁö¿¬ ±³¼ö (°¡Ãµ´ëÇб³)
15:45-16:10 Nutritional Interventions to Mitigate Muscle Loss ±èÇö¼÷ ±³¼ö (ÇѾç´ëÇб³)
16:10-16:35 Digital Therapeutics and AI-driven Solutions for Sarcopenia Treatment Áö¼ºÈ¯ ¿¬±¸¿ø
(»ï¼ºÀ¶ÇÕÀÇ°úÇпø)
16:35-16:50 ±¸¿¬ ¹× Æ÷½ºÅÍ ½Ã»ó ¹× Á¤±â ÃÑȸ ¡¡

¼ÒÇÐȸÀå(´ëȸÀǽÇ)

Session VI  ÀÚÀ¯¿¬Á¦
ÁÂÀå: ÇÏ¿ëÂù (ºÎ¹Îº´¿ø), ÀÌ¿µ±Õ (¼­¿ïÀÇ´ë)
09:30-10:15 ÀÚÀ¯ ¿¬Á¦  
Session VII  Advances in Tissue Engineering and Biomaterials for Musculoskeletal Regeneration
ÁÂÀå: ÀÌÀ±½Ç(¼­¿ï´ëÇб³ Ä¡°ú´ëÇÐ), ±èÁ¤Àº(°æºÏÀÇ´ë)
11:00-11:30 Development of Muscle Models in Microphysiological System Àü¼ºÀ± ±³¼ö (KAIST)
11:30-12:00 Advanced Tissue Engineering for Muscle Regeneration Á¶½Â¿ì ±³¼ö (¿¬¼¼ÀÇ´ë)
12:00-12:30 Adhesive Hydrogel Electrodes for Peripheral Nerve and Muscle Interfaces ½Å¹Ì°æ ±³¼ö (¼º±Õ°ü´ëÇб³)
Luncheon Symposium & Lunch
ÁÂÀå: ±èųâ (ÀÎÁ¦ÀÇ´ë)
12:30-13:30 1. ±Ù°¨¼ÒÁõ ȯÀÚ¿¡¼­ Å×½ºÅ佺Å×·ÐÀÇ »ç¿ë
2. ½º¸¶Æ® ÀμÖÀ» ÀÌ¿ëÇÑ ±Ù°¨¼ÒÁõ ȯÀÚ °ü¸®
À¯ÁØÀÏ ±³¼ö (ÀÎÇÏÀÇ´ë)
Session VIII  Emerging Therapeutic Targets for Sarcopenia
ÁÂÀå: ±èÀÏ¿µ(°¡ÃµÀÇ´ë), ÀüÀçÇÑ(¾Æº¥Æ¼)
13:30-14:00 Exercise-induced CLCF1 Reverses Age-related Skeletal Muscle and Bone Decline ¾ç¿ë·Ä ¹Ú»ç
(Çѱ¹»ý¸í°øÇבּ¸¿ø)
14:00-14:30 Identification and Validation of MASAP as a Universal Blood Biomarker for Sarcopenia Á¶À±ÁÖ ¹Ú»ç (GIST)
14:30-15:00 Protein Arginine Methyltransferase 1 is Essential for Neuromuscular Junction and Mitochondrial Homeostasis Via Mitophagy Regulation ¹èÁÖÇö ¹Ú»ç(¼º±Õ°ü´ëÇб³)
15:00-15:20 Coffee Break ¡¡
Session IX  Respiratory Sarcopenia: Concepts, Evaluation, and Training Approaches
ÁÂÀå: ±èµ·±Ô (Áß¾ÓÀÇ´ë), ÀÓÀ翵 (¼­¿ïÀÇ´ë)
15:20-15:50 Defining Respiratory Sarcopenia: Cutoff Values Using MIP and MEP ½Å¸íÁØ ±³¼ö (ºÎ»êÀÇ´ë)
15:50-16:20 Assessment and Training Methods for Respiratory Muscle Strength (MIP/MEP) ¹Úżº ±³¼ö (ºÎ»ê´ëÇб³º´¿ø)
16:20-16:30 Discussion